Los Angeles Capital Management’s Novavax NVAX Stock Holding History

Los Angeles Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.13K	Hold	757	–	–	﹤0.01%	2038
2026 Q1	$6.16K	Sell	757 -75	-9%	-$680	﹤0.01%	2071
2025 Q4	$7.01K	Buy	+832	New	+$6.27K	﹤0.01%	2206
2025 Q3	–	Sell	-19,591	Closed	-$123K	–	1479
2025 Q2	$123K	Buy	+19,591	New	+$130K	﹤0.01%	1239
2024 Q4	–	Sell	-29,112	Closed	-$368K	–	1204
2024 Q3	$368K	Buy	+29,112	New	+$376K	﹤0.01%	948
2022 Q1	–	Sell	-1,438	Closed	-$206K	–	1469
2021 Q4	$206K	Sell	1,438 -1,320	-48%	-$227K	﹤0.01%	1341
2021 Q3	$572K	Sell	2,758 -4,835	-64%	-$1.07M	﹤0.01%	992
2021 Q2	$1.61M	Sell	7,593 -263	-3%	-$48.2K	0.01%	644
2021 Q1	$1.42M	Sell	7,856 -2,205	-22%	-$439K	0.01%	745
2020 Q4	$1.12M	Buy	+10,061	New	+$1.07M	﹤0.01%	887

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Los Angeles Capital Management's NVAX Position: Q2 2026 in Review

Los Angeles Capital Management held its Novavax (NVAX) position steady in Q2 2026 at 757 shares worth $7.13K. The position accounts for ﹤0.01% of the portfolio, ranked #2038.

Los Angeles Capital Management first reported a position in NVAX in Q4 2020 and has held it in 10 quarters since. The position peaked at $1.61M in Q2 2021. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Los Angeles Capital Management held 757 shares of Novavax worth $7.13K as of Q2 2026.
Los Angeles Capital Management left its Novavax share count unchanged in Q2 2026.
Novavax made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #2038 holding.
Los Angeles Capital Management first reported a position in Novavax in Q4 2020 and has held it in 10 quarters since.
Los Angeles Capital Management's Novavax position peaked at $1.61M in Q2 2021.
268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.